Immatics NV (IMTX)
10.90
0.00 (0.00%)
USD |
NASDAQ |
May 03, 12:04
Immatics Cash from Operations (TTM): 19.73M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 19.73M |
September 30, 2023 | -93.20M |
June 30, 2023 | -93.39M |
March 31, 2023 | -40.38M |
December 31, 2022 | 105.60M |
September 30, 2022 | 102.41M |
June 30, 2022 | 109.77M |
Date | Value |
---|---|
March 31, 2022 | 40.31M |
December 31, 2021 | -100.27M |
September 30, 2021 | -92.28M |
June 30, 2021 | -105.72M |
March 31, 2021 | -99.59M |
December 31, 2020 | -92.16M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-105.72M
Minimum
Jun 2021
109.77M
Maximum
Jun 2022
-26.09M
Average
-92.16M
Median
Dec 2020
Cash from Operations (TTM) Benchmarks
MorphoSys AG | -- |
Affimed NV | -119.38M |
InflaRx NV | -40.94M |
BioNTech SE | 5.815B |
CureVac NV | -290.02M |